Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Protherics Releases Positive Data From Hypertension Trial

April 3, 2002

Celltech Signs Drug Conjugate Deal With Seattle Genetics

April 3, 2002

Protherics Releases Positive Data From Hypertension Trial

April 3, 2002

Astex, Aventis Collaborate On Drug-Metabolizing Enzymes

April 3, 2002

British Biotech Receives FDA Approval For BB-10153 Trial

April 3, 2002

Vernalis Seeks Second Nasdaq Listing, Reports Profitability

March 27, 2002

ReGen’s Phase IIa Interim Data Not Significant In Alzheimer’s

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

Avidex Platform Creates TCRs; Company Planning Partnerships

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...